Your browser doesn't support javascript.
loading
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review.
Mattana, Francesco; Muraglia, Lorenzo; Rajwa, Pawel; Zattoni, Fabio; Marra, Giancarlo; Chiu, Peter K F; Heidegger, Isabel; Kasivisvanathan, Veeru; Kesch, Claudia V; Olivier, Jonathan; Preisser, Felix; Thibault, Constance; Valerio, Massimo; van den Bergh, Roderick C N; Gandaglia, Giorgio; Ceci, Francesco.
Afiliación
  • Mattana F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Muraglia L; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Rajwa P; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Zattoni F; Department of Surgery, Oncology and Gastroenterology, Urology Clinic, University of Padova, Padova, Italy.
  • Marra G; Division of Urology, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Università di Torino, Turin, Italy.
  • Chiu PKF; SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong.
  • Heidegger I; Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
  • Kasivisvanathan V; Division of Surgery and Interventional Science, University College London, London, UK.
  • Kesch CV; Department of Urology, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
  • Olivier J; Department of Urology, Lille University Hospital, Lille, France.
  • Preisser F; Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Thibault C; Department of Medical Oncology, European Georges Pompidou Hospital, Assistance Publique des Hôpitaux de Paris, Paris Descartes University, Paris, France.
  • Valerio M; Department of Urology, Lausanne University Hospital, Lausanne, Switzerland.
  • van den Bergh RCN; Department of Urology, Antonius Hospital, Utrecht, The Netherlands.
  • Gandaglia G; Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
  • Ceci F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: francesco.ceci@ieo.it.
Eur Urol Oncol ; 6(2): 128-136, 2023 04.
Article en En | MEDLINE | ID: mdl-36804735
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans / Male Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans / Male Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Países Bajos